Carbon monoxide (CO) is a colorless, odorless gas produced by incomplete combustion that binds hemoglobin with >200× the affinity of oxygen, causing tissue hypoxia, oxidative stress, and inflammatory injury primarily to the brain and heart. [1-3] It is a leading cause of poisoning deaths in the United States, with ~50,000 ED visits annually. [2]
The following figure illustrates the progressive spectrum of clinical effects based on CO exposure level and duration:
1. History
- Source of exposure: Faulty furnace/heater, vehicle exhaust in enclosed space, generator use indoors, house fire/smoke inhalation, charcoal grill, gas appliances, occupational (forklifts, pressure washers, gasoline-powered tools) [3-5]
- Duration of exposure: How long in the environment? When did symptoms begin?
- Symptom characterization: Headache (most common), dizziness, nausea/vomiting, fatigue, confusion, chest pain, dyspnea, syncope [1][3]
- Timing/triggers: Symptoms worse indoors, improve when leaving the environment ("weekend headache" pattern); seasonal — more common in winter months [6-7]
- Co-exposures: Others in the household or workplace with similar symptoms (cluster presentation is a classic clue) [3]
- Intentionality: Suicidal intent (vehicle exhaust, charcoal burning in enclosed space) — screen for co-ingestants [3-4]
- Important negatives: No fever, no sick contacts (helps distinguish from viral illness), no prior similar episodes unrelated to environment
2. Alarm Features
- Loss of consciousness or syncope [8-9]
- Altered mental status, confusion, seizures [2][4]
- Chest pain, dysrhythmia, signs of myocardial ischemia [3][10]
- Severe metabolic acidosis (lactate >2 mmol/L suggests tissue hypoxia) [8][11]
- Pregnancy (fetal hemoglobin has even higher CO affinity) [12]
- COHb ≥25% [13]
- Cherry-red skin — classically described but rarely seen clinically; more often a postmortem finding
- Multiple household members presenting simultaneously — suggests ongoing environmental hazard requiring immediate notification of fire department/utility company
3. Medications
- Primary treatment: 100% O₂ via high-flow nonrebreather mask (NRB) — reduces CO elimination half-life from ~5 hours (room air) to ~85 minutes [2-3]
- Hyperbaric oxygen (HBO₂): Reduces half-life to ~20 minutes; the 2025 ACEP Clinical Policy provides a Level C recommendation that selected symptomatic patients may benefit based on severity and HBO₂ availability [2]
- No specific pharmacologic antidote exists; alternative pharmacological treatments remain experimental [12]
- Co-ingestant screening: In intentional exposures, check for alcohol, benzodiazepines, opioids, acetaminophen, aspirin [3]
- Caution: Standard pulse oximetry is unreliable — it cannot distinguish COHb from oxyhemoglobin and will read falsely normal [1][7]
4. Diet
- Not a primary consideration in acute management
- Hydration: Ensure adequate IV hydration, particularly in patients with rhabdomyolysis or metabolic acidosis
- No specific dietary triggers or long-term dietary management
5. Review of Systems
- Neurologic: Headache, dizziness, confusion, visual changes, ataxia, memory difficulty, personality changes [3]
- Cardiac: Chest pain, palpitations, dyspnea on exertion [10]
- GI: Nausea, vomiting, abdominal pain [1]
- Psychiatric: Anxiety, depression, irritability (may be early or delayed) [2]
- Musculoskeletal: Myalgias, weakness (consider rhabdomyolysis in prolonged exposures) [9]
- Constitutional: Fatigue, malaise — often mistaken for viral illness [6][14]
6. Collateral History and Family History
- Collateral: Are other household members, coworkers, or pets symptomatic? This is a critical diagnostic clue [3]
- Exposure source: Who else was in the environment? Has the fire department or utility company been notified?
- Intentional exposure: Collateral from family/friends regarding suicidal ideation, psychiatric history
- Family history: Pre-existing coronary artery disease or cardiac conditions increase vulnerability to CO-induced cardiac injury; CO can unmask familial Brugada syndrome [10]
7. Risk Factors
- Environmental: Faulty heating systems, poorly ventilated spaces, indoor use of generators/grills/combustion engines, house fires [3-4][6]
- Seasonal: Winter months (December–February) account for ~41% of non-fire-related exposures [6]
- Occupational: Construction, natural resources, maintenance workers; forklift operators; use of gasoline-powered tools in enclosed spaces [5]
- Demographic: Males more likely to die from CO poisoning; occupational exposures more common in younger, male, Hispanic workers [5][15]
- Comorbidities increasing vulnerability: Pre-existing coronary artery disease, anemia, COPD, pregnancy [3][10]
- Behavioral: Suicide attempts (vehicle exhaust, charcoal burning) [4][16]
8. Differential Diagnosis
- Viral syndrome / influenza — the most common misdiagnosis; key distinguishing feature is absence of fever and cluster presentation [2][14]
- Cyanide poisoning — consider in fire/smoke inhalation; persistent hypotension and severe lactic acidosis (>10 mmol/L) despite adequate oxygenation suggest cyanide co-poisoning [4][17]
- Hydrogen sulfide poisoning — "rotten egg" odor, occupational exposure in sewers/confined spaces [4]
- Methemoglobinemia — cyanosis unresponsive to O₂, chocolate-brown blood
- Acute coronary syndrome — CO can cause true myocardial ischemia/infarction even with normal coronaries [10][18]
- Tension headache / migraine — recurrent headaches that resolve on leaving the home should raise suspicion for chronic low-level CO exposure [3]
- Stroke / intracranial pathology — focal neurologic deficits
- Drug/alcohol intoxication — especially in intentional exposures with co-ingestants
9. Past Medical History
- Coronary artery disease: Increased risk of CO-induced myocardial ischemia [3][10]
- Anemia: Reduced oxygen-carrying capacity compounds CO toxicity
- COPD/asthma: Impaired gas exchange worsens hypoxia
- Pregnancy: Fetal hemoglobin binds CO with higher affinity; lower threshold for HBO₂ [12]
- Psychiatric history: Prior suicide attempts, depression (relevant for intentional exposures)
- Previous CO exposure: Prior episodes increase risk of cumulative neurologic injury
10. Physical Exam
- Vital signs: Tachycardia, tachypnea, hypotension (in severe cases); SpO₂ will be falsely normal — do not rely on pulse oximetry [1][7]
- Neurologic: Mental status assessment (GCS), cerebellar exam (ataxia, dysmetria), cognitive screening (orientation, short-term memory), pupillary exam
- Cardiovascular: Murmurs, signs of heart failure, irregular rhythm
- Respiratory: Assess for concurrent smoke inhalation injury (stridor, soot in airway, singed nasal hairs)
- Skin: Cherry-red discoloration is rare in living patients; more commonly skin appears normal or pale
- Musculoskeletal: Compartment syndrome in prolonged unconscious exposures (check for tense compartments)
11. Lab Studies
- COHb level via co-oximetry (venous is adequate for diagnosis): [3]
- >3% in nonsmokers or >10% in smokers confirms exposure
- COHb does not correlate well with clinical severity or outcomes [3][8]
- Levels may be falsely low if O₂ was administered prehospital
- ABG/VBG: Assess pH, lactate, PaO₂ (PaO₂ may be normal despite tissue hypoxia) [3-4]
- Serum lactate: Elevated lactate correlates with severity; combined with COHb, AUC of 0.936 for predicting HBO₂ need [11]
- Troponin I, BNP/NT-proBNP: Screen for myocardial injury in all patients [3][10]
- BMP: Assess renal function, electrolytes
- CK: If prolonged immobilization or unconsciousness (rhabdomyolysis)
- Toxicology screen: In intentional exposures — alcohol, acetaminophen, salicylates, urine drug screen [3]
- Pregnancy test: In women of childbearing age (changes management threshold for HBO₂)
12. Imaging
- Chest X-ray: Baseline; assess for pulmonary edema (severe poisoning) or concurrent smoke inhalation injury
- CT head: If altered mental status, focal neurologic deficits, or concern for alternative diagnosis (stroke)
- Brain MRI: Gold standard for detecting CO-related brain injury; classic findings include bilateral globus pallidus lesions and diffuse white matter changes; acute brain lesions on MRI predict delayed neurological sequelae (DNS) [13]
- Echocardiography (TTE): If troponin elevated or ECG abnormalities — assess for wall motion abnormalities, LV dysfunction [10]
- Imaging is not routinely needed in mild cases with rapid symptom resolution
13. Special Tests
- CO-oximetry (blood gas analyzer with co-oximetry capability): The definitive diagnostic test — standard pulse oximetry and standard ABG PaO₂ do not detect COHb [1][3]
- Pulse CO-oximetry (noninvasive): Can be used for triage screening, though less accurate than blood co-oximetry [7]
- Neuropsychometric testing: Formal cognitive testing at follow-up to detect delayed neurological sequelae [3]
- COPCAB score: A validated clinical scoring model incorporating age, GCS, intubation status, and lactate to predict poor neurocognitive outcomes at 1 month [16]
14. ECG
ECG should be obtained in all patients with confirmed CO poisoning. [3][10][12]
- Sinus tachycardia: Most common finding (~15–58% of cases) [10][19]
- ST-segment changes: Both STEMI and NSTEMI patterns reported, even with normal coronary arteries (coronary vasospasm) [10][18]
- QT prolongation: Indicates ventricular repolarization heterogeneity and predisposes to ventricular arrhythmias [10]
- Atrial fibrillation, PACs, PVCs, wandering pacemaker [10]
- Brugada pattern: CO can unmask familial Brugada syndrome [10]
- Monitor for 3–7 days if new ECG abnormalities are detected [10]
The following algorithm outlines the approach to evaluating cardiac injury in CO poisoning:
15. Assessment
- Severity stratification: [8][20]
- Mild: COHb 10–20%, headache, nausea, dizziness — symptoms resolve with O₂
- Moderate: COHb 20–30%, confusion, muscle weakness, impaired cognition
- Severe: COHb >30%, loss of consciousness, seizures, myocardial ischemia, severe acidosis, coma
- COHb levels are a rough guide but do not reliably predict outcomes — clinical severity should drive management [3][8]
- Delayed neurological sequelae (DNS) can develop 2–40 days after initial exposure, ranging from memory/concentration deficits to Parkinsonism, psychosis, and dementia [2-3]
- DNS occurs in up to ~25–46% of patients treated with normobaric oxygen alone [3][16]
16. Treatment Plan
Initial stabilization
- Remove from CO source; ensure scene safety
- 100% O₂ via NRB mask immediately — continue until COHb <5% [3]
- Intubation with 100% FiO₂ if GCS ≤8, airway compromise, or respiratory failure
- IV access, cardiac monitoring, continuous pulse oximetry (recognizing its limitations)
Hyperbaric oxygen therapy (HBO₂)
- The 2025 ACEP Clinical Policy (Level C): Selected symptomatic patients may benefit from HBO₂ based on severity and availability [2]
- Commonly accepted indications (though not universally standardized): Loss of consciousness, neurologic deficits, cardiac ischemia, severe metabolic acidosis, COHb ≥25%, pregnancy [12-13]
- Optimal timing: Within 6 hours of exposure yields best neurocognitive outcomes; treatment within 24 hours is generally recommended [16][21]
- Protocol: Typically 2.5–3.0 ATA for 90–150 minutes; some protocols include up to 3 sessions within 24 hours [3][8]
- Risks of HBO₂: Middle ear barotrauma, oxygen toxicity seizures, claustrophobia, clinical deterioration during transport [2]
Concurrent smoke inhalation
- cyanide poisoninghydroxocobalamin[4]
Cardiac injury management
- Cardiology consultation if troponin elevated or STEMI pattern on ECG [3][10]
- TTE for wall motion assessment [10]
17. Disposition
Admission criteria
- Loss of consciousness, persistent neurologic deficits, or altered mental status [8]
- Myocardial ischemia or significant ECG abnormalities [10]
- Severe metabolic acidosis
- COHb ≥25% [13]
- Pregnancy with significant exposure
- Intentional exposure (psychiatric admission/evaluation after medical stabilization)
- Need for HBO₂ therapy
Observation indications
- Moderate symptoms with improving trajectory on NBO
- Awaiting COHb normalization (<5%)
Discharge criteria
- Symptom resolution after NBO therapy
- COHb <5% [3]
- Normal ECG and troponin
- Normal neurologic exam
- Safe environment confirmed (CO source identified and remediated; fire department/utility company notified)
- No concern for intentional self-harm
Specialist consultation triggers
- Toxicology/Poison Control: All moderate-to-severe cases; guidance on HBO₂ indications
- Cardiology: Elevated troponin, ECG ischemic changes
- Psychiatry: Intentional exposures
- Hyperbaric medicine: When HBO₂ is being considered
18. Follow Up / Return Precautions
- Follow-up timing: Within 1–2 weeks for neurocognitive reassessment; formal neuropsychometric testing at 4–6 weeks to screen for DNS [3][16]
- Delayed neurological sequelae can appear 2–40 days post-exposure — patients must be counseled about this risk [2]
- Return immediately for: New or worsening headache, confusion, memory problems, personality changes, difficulty walking, chest pain, palpitations, or any new neurologic symptoms [3]
- Patient counseling:
- Install and maintain CO detectors in the home [3]
- Arrange furnace/appliance inspection before returning home [3]
- Never operate generators, grills, or combustion engines indoors or in enclosed spaces [6]
- Patients should be informed they may not fully recover after poisoning [3]
- Expected recovery: Mild cases typically resolve fully; severe cases carry risk of permanent cognitive deficits, Parkinsonism, or cardiac complications [2][22]
- Cardiac follow-up: If myocardial injury was detected, outpatient cardiology follow-up with repeat ECG and echocardiography is recommended [10]
References
1. Carbon Monoxide Poisoning. — Chenoweth JA, Albertson TE, Greer MR. Critical Care Clinics. 2021.
2. Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Acute Carbon Monoxide Poisoning (2025). — Richard D. Shih, Christian A. Tomaszewski, Amy Kaji, et al American College of Emergency Physicians. 2025.
3. Carbon Monoxide Poisoning. — Weaver LK. The New England Journal of Medicine. 2009.
4. Hazardous Chemical Emergencies and Poisonings. — Henretig FM, Kirk MA, McKay CA. The New England Journal of Medicine. 2019.
5. Occupational Carbon Monoxide Poisoning in Wisconsin: Results From a Statewide Electronic Disease Surveillance System and From the Wisconsin Poison Center, 2018-2021. — Andreychak EM, Tomasallo CD, Idowu D, Gummin DD, Meiman JG. Public Health Reports. 2024.
6. Nonfatal, Unintentional, Non--Fire-Related Carbon Monoxide Exposures--United States, 2004-2006. — MMWR. Morbidity and Mortality Weekly Report. 2008.
7. Carbon Monoxide Poisoning Cases Presenting With Non-Specific Symptoms. — Deniz T, Kandis H, Eroglu O, et al. Toxicology and Industrial Health. 2017.
8. Hyperbaric-Oxygen Therapy. — Tibbles PM, Edelsberg JS. The New England Journal of Medicine. 1996.
9. Carbon Monoxide Intoxication. — Kales SN. American Family Physician. 1993.
10. Practical Recommendations for the Evaluation and Management of Cardiac Injury Due to Carbon Monoxide Poisoning. — Cho DH, Thom SR, Son JW, Ko SM, Cha YS. JACC. Heart Failure. 2024.
11. Serum Lactate and Carboxyhemoglobin as Predictors of Hyperbaric Oxygen Therapy in Carbon Monoxide Poisoning: A Retrospective Study. — Aykut A, Günsoy E, Karabulut BÖ, et al. BMC Emergency Medicine. 2025.
12. The Diagnosis and Treatment of Carbon Monoxide Poisoning. — Eichhorn L, Thudium M, Jüttner B. Deutsches Arzteblatt International. 2018.
13. Acute Brain Lesions on Magnetic Resonance Imaging and Delayed Neurological Sequelae in Carbon Monoxide Poisoning. — Jeon SB, Sohn CH, Seo DW, et al. JAMA Neurology. 2018.
14. Clinical Chameleons: An Emergency Medicine Focused Review of Carbon Monoxide Poisoning. — Ng PC, Long B, Koyfman A. Internal and Emergency Medicine. 2018.
15. Unintentional Non-Fire-Related Carbon Monoxide Exposures--United States, 2001-2003. — MMWR. Morbidity and Mortality Weekly Report. 2005.
16. Derivation and Validation of a Score for Predicting Poor Neurocognitive Outcomes in Acute Carbon Monoxide Poisoning. — Kim SH, Lee Y, Kang S, et al. JAMA Network Open. 2022.
17. Acute Chemical Emergencies. — Kales SN, Christiani DC. The New England Journal of Medicine. 2004.
18. Non-Infarctual ST Elevation and Acute Cardiopulmonary Failure in Carbon Monoxide Poisoning: A Case Report. — Longhitano Y, Candelli M, Muir HA, et al. European Review for Medical and Pharmacological Sciences. 2019.
19. Asymmetric Dimethylarginine and Heart-Type Fatty Acid-Binding Protein 3 Are Risk Markers of Cardiotoxicity in Carbon Monoxide Poisoning Cases in Zagazig University Hospitals. — Abass MA, Arafa MH, El-Shal AS, Atteia HH. Human & Experimental Toxicology. 2017.
20. Fire-Related Inhalation Injury. — Sheridan RL. The New England Journal of Medicine. 2016.
21. Effect of Hyperbaric Oxygen Therapy Initiation Time in Acute Carbon Monoxide Poisoning. — Lee Y, Cha YS, Kim SH, Kim H. Critical Care Medicine. 2021.
22. Early and Late Adverse Clinical Outcomes of Severe Carbon Monoxide Intoxication: A Cross-Sectional Retrospective Study. — Vural A, Dolanbay T. PloS One. 2024.